ZNF671 and cancer: Having demonstrated that the potential tumor suppressor ZNF671 is epigenetically silenced in UC, and in consideration of other cancer biomarkers found in human urine [17, 34], we assessed the feasibility of using ZNF671 methylation as a biomarker for non-invasive cancer detection in urine.